Biotechnology News

PHILADELPHIA, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Aro Biotherapeutics, a clinical-stage biotechnology company developing targeted short-interfering RNA (siRNA) medicines for the treatment of diseases...

Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema

Kraig Labs (OTCQB: KBLB) reached a significant commercialization milestone, shipment of its first commercial spider silk order

20/20 BioLabs to Host Investor Webinar on October 7, 2026 to Discuss FDA Advisory Committee Vote and New OneTest™ Franchise Model

GATC’s Derisq™, the definitive AI report for predictive risk intelligence, named a Top Emerging Startup Technology by independent panel of life sciences experts at the esteemed publication. IRVINE,...

Celularity appoints Viome founder and CEO Naveen Jain to its Board, adding expertise in technology, personalized health, longevity and innovation.

More than 94% of participants achieved a ≥5-point MG-ADL improvement at Week 48 42% of telitacicept-treated participants achieved minimal symptom expression (MSE) at any time over 48 weeks,...

New data show deepening improvement in ocular MG and sustained one-year efficacy in anti-AChR antibody-negative MG – broadening VYVGART's potential to treat all MG patientsReal-world evidence from...

U.S. FDA has granted Fast Track designation for TX2100 in HHT and cleared the Investigational New Drug (IND) application for the TX2100 Phase 1b clinical trial in HHT patients in the U.S.TX2100 Phase...

SAN FRANCISCO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Claris Biotherapeutics, Inc., a late-stage biopharmaceutical company dedicated to advancing transformative therapies for sight-threatening...